Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELOXX PHARMACEUTICALS, INC.

(ELOX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ELOXX PHARMACEUTICALS, INC.
01/05ELOXX PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listin..
AQ
2021Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Pric..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral ..
MT
2021ELOXX PHARMACEUTICALS : Topline ELX-02 Phase 2 Results Call and Webcast
PU
2021Eloxx Pharmaceuticals' Mid-Stage Cystic Fibrosis Trial Meets Key Secondary Endpoint, Sa..
MT
2021ELOXX PHARMACEUTICALS : Reports Positive Topline Results from Monotherapy Arms of Phase 2 ..
PU
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
CI
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neut..
MT
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
PU
2021Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
CI
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
AQ
2021ELOXX PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
2021Eloxx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
CI
2021ELOXX PHARMACEUTICALS : Webcast and Conference Call
PU
2021ELOXX PHARMACEUTICALS : to Host Investor and Analyst Call and Webcast on Cystic Fibrosis P..
GL
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Termination of a..
AQ
2021HERCULES CAPITAL : Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from H..
AQ
2021Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
CI
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
2021Eloxx Pharmaceuticals, Inc. announced that it expects to receive $30 million in funding..
CI
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure (form 8-K)
AQ
2021Eloxx Pharmaceuticals 15% Higher After FDA Fast Track Designation
DJ
2021ELOXX PHARMACEUTICALS' : ELX-02 Receives US FDA Fast-Track Designation to Treat Cystic Fib..
MT
2021ELOXX PHARMACEUTICALS : Announces Fast Track Designation for ELX-02 for the Treatment of C..
AQ
2021Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of ..
CI
2021Eloxx Pharmaceuticals Gets FDA Fast Track Designation for ELX-02 in Cystic Fibrosis
DJ
2021ELOXX PHARMACEUTICALS : Appoints Chief Medical Officer
AQ
2021Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
CI
2021ELOXX PHARMACEUTICALS : Files $200 Million Mixed Shelf
MT
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Principal Accounting Officer
CI
2021ELOXX PHARMACEUTICALS : Reports Second Quarter 2021 Financial and Operating Results and Pr..
PU
2021ELOXX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021Eloxx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June ..
CI
2021ELOXX PHARMACEUTICALS : Reports Second Quarter 2021 Financial and Operating Results and Pr..
AQ
2021Eloxx Pharmaceuticals, Inc. Provides Business Update
CI
2021Certain Common Stock of Eloxx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement ..
CI
2021Certain Warrants of Eloxx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Endi..
CI
2021Certain Options of Eloxx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Endin..
CI
2021Certain Restricted Stock Units of Eloxx Pharmaceuticals, Inc. are subject to a Lock-Up ..
CI
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021ELOXX PHARMACEUTICALS : Corporate Controller, Treasurer Resigns
MT
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Gary Rakers to Resign as Executive Director, Finance & Accounting, Corporate Conroller ..
CI
2021ELOXX PHARMACEUTICALS : Provides Enrollment Update for Ongoing Phase 2 Clinical Studies fo..
PU
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regulation FD Dis..
AQ
2021Eloxx Pharmaceuticals, Inc. Announces the departure of Neil Belloff as Chief Operating ..
CI
2021ELOXX PHARMACEUTICALS : Pharma Expects Part of Mid-Stage Cystic Fibrosis Trial Data in Q4
MT
2021Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies f..
GL
2021Eloxx Pharmaceuticals, Inc. Provides Enrollment Update for Ongoing Phase 2 Clinical Stu..
CI
2021ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 P..
MT
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell Small Cap Completeness I..
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 3000 Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 3000E Growth Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 3000E Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 2000 Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell Small Cap Comp Growth In..
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 2500 Growth Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 3000 Growth Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 2000 Growth Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 2500 Index
CI
2021ELOXX PHARMACEUTICALS, INC.(NASDAQGM : ELOX) dropped from Russell 2000 Dynamic Index
CI
2021ELOXX PHARMACEUTICALS : Financial Statements and Exhibits (form 8-K/A)
AQ
2021ELOXX PHARMACEUTICALS : Roche Discloses 5.3% Stake in Eloxx Pharmaceuticals
MT
2021ELOXX PHARMACEUTICALS : Announces Funding Award from Cystic Fibrosis Foundation for Develo..
PU
2021ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : Secures $2.6 Million Funding Award for Development of Ribosome Mod..
MT
2021ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Com..
MT
2021Eloxx Pharmaceuticals Announces Funding Award from Cystic Fibrosis Foundation for Devel..
GL
2021ELOXX PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2021ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 ..
MT
2021ELOXX PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock Including Ful..
AQ
2021ELOXX PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock Including Ful..
PU
1  2  3  4Next
Upcoming event on ELOXX PHARMACEUTICALS, INC.
03/10/22